$57.60-1.34 (-2.27%)
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and internationally.
Stepan Company in the Basic Materials sector is trading at $57.60 with a market capitalization of $1.2B. The stock is currently 15% below its 52-week high of $68.00, remaining 14.3% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $604.51M↑ | $553.89M↓ | $590.28M↓ | $594.69M↑ | $593.25M |
| Gross Profit | $64.85M↑ | $51.52M↓ | $71.02M↓ | $71.89M↓ | $75.46M |
| Operating Income | $15.82M↑ | $1.33M↓ | $21.79M↑ | $17.96M↓ | $28.29M |
| Net Income | -$41.41M↓ | $5.00M↓ | $10.84M↓ | $11.34M↓ | $19.71M |
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland, the United Kingdom, Brazil, Mexico, and international...
Kronos Worldwide (KRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Petroleum additives giant NewMarket could find a perfect, synergistic fit with the company's core business.
Stepan (SCL) is back on investors’ radar after recent trading pressure, with the stock down 4% over the past month and 26% over the past 3 months, which has sharpened the focus on fundamentals. See our latest analysis for Stepan. Recent trading has been weak, with the stock down 26% on a 90 day share price return basis and the 1 year total shareholder return slipping 9%, pointing to fading momentum despite a positive year to date share price return of 4%. If Stepan’s recent pullback has you...
Stepan Co (SCL) reports strong safety achievements and growth in specialty products, despite facing restructuring charges and market pressures.
Stepan (NYSE:SCL) reported a first-quarter 2026 net loss as restructuring charges tied to its asset footprint changes overshadowed modest organic sales growth and mixed segment performance. Management also emphasized progress on its multi-year cost and asset optimization initiative, Project Catalyst